Poly Medicure Limited has submitted a regulatory disclosure pursuant to Regulation 30 and applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III Part A.
The company intimates that its officials will hold a one-on-one meeting with analysts/investors according to the following schedule:
Meeting Details:
- Participant: Sumitomo Mitsui DS Asset Management
- Date: Tuesday, September 8, 2026
- Time: 09:30 AM
- Venue: Registered Office - 232-B, 3rd Floor, Okhla Industrial Estate, Phase III, New Delhi - 110 020
- Meeting Type: One-on-One
The disclosure notes that the schedule is subject to changes due to exigencies on the part of the analysts, investors, or the company. The company explicitly states that no unpublished price sensitive information will be shared during the meeting.
The document is digitally signed by Avinash Chandra, Company Secretary (Membership No. A32270), on September 2, 2026, at 16:14:47 +05:30.